|
Re: Apabetalone’s Positive Effect on Hospitalized Patients Involving HF - simple suggestion
|
5
|
Resverlogix Corp.
|
Jan 13, 2021 06:30PM
|
|
Re: Presentation is over
|
5
|
Resverlogix Corp.
|
Jun 09, 2020 08:34AM
|
|
RVX Announces Update Webcast and Conference Call
|
5
|
Resverlogix Corp.
|
Jan 18, 2021 07:31AM
|
|
Tweet from Prof Kausik Ray
|
5
|
Resverlogix Corp.
|
May 31, 2020 11:40PM
|
|
Re: Tweet from Prof Kausik Ray
|
5
|
Resverlogix Corp.
|
May 31, 2020 11:59PM
|
|
Screening for COVID / RVX 208 trial
|
5
|
Resverlogix Corp.
|
Feb 04, 2021 03:50PM
|
|
Re: PNAS - jbuffet
|
5
|
Resverlogix Corp.
|
Jan 02, 2021 01:33PM
|
|
Re: Report of exempt distribution
|
5
|
Resverlogix Corp.
|
May 07, 2020 02:26PM
|
|
Starting Dialysis Sooner Leads to Poorer Outcomes
|
5
|
Resverlogix Corp.
|
May 14, 2020 04:25PM
|
|
Re: Summary of Proposed BETonMACE2 design and timelines
|
5
|
Resverlogix Corp.
|
Feb 05, 2021 07:04PM
|
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
5
|
Resverlogix Corp.
|
Jun 13, 2020 10:26AM
|
|
Lower LDL-C and Increased Type 2 Diabetes Risk
|
5
|
Resverlogix Corp.
|
Jun 03, 2020 08:02PM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
5
|
Resverlogix Corp.
|
Jun 22, 2020 08:50AM
|
|
Re: The problem...as I see it ...further to my last
|
5
|
Resverlogix Corp.
|
Oct 18, 2020 11:12AM
|
|
Re: Saudi
|
5
|
Resverlogix Corp.
|
Apr 07, 2021 03:10PM
|
|
Re: Interim Analysis
|
5
|
Resverlogix Corp.
|
Oct 15, 2020 08:26PM
|
|
Lots of new options and deferred share units issued on Friday
|
5
|
Resverlogix Corp.
|
May 06, 2020 09:18AM
|
|
Re: June 9th NR
|
6
|
Resverlogix Corp.
|
Jun 14, 2020 11:49AM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
6
|
Resverlogix Corp.
|
Mar 26, 2020 08:47AM
|
|
Upgrade ? PP ? COVID 19 ?
|
6
|
Resverlogix Corp.
|
Jan 18, 2021 02:42PM
|
